Pure red cell aplasia (PRCA) is a complication of ABO-incompatible allogeneic stem cell transplantation. The mechanism is not well known, although the isoagglutinin titer before transplantation or cyclosporine use is considered to be the cause. Patients with this complication require more blood transfusions than those without it. There is no standard treatment. We report two cases of PRCA after allogeneic peripheral blood stem cell transplantation that were successfully treated with plasma exchange and low-dose steroid
Parvovirus B19 is recognized as a rare cause of pure red cell aplasia (PRCA) in allogeneic stem cell...
Background: Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoie...
ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic stem cell tr...
Pure red cell aplasia (PRCA) is a complication of ABO-incompatible allogeneic stem cell transplantat...
AbstractNo standard of care for pure red cell aplasia (PRCA) after major ABO-incompatible hematopoie...
Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has...
BACKGROUND: Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoie...
We studied a patient who developed pure red cell aplasia (PRCA) following peripheral stem cell trans...
Major ABO incompatibility in stem cell transplant recipients has been associated with pure red cell ...
BACKGROUND: Major ABO mismatch in hematopoietic progenitor cell transplantation (HPCT) is associated...
Pure red cell aplasia (PRCA) is a rare complication in recipients of allogenic stem cell from ABO in...
Acquired pure red cell aplasia (PRCA) is an uncommon cause of anemia in a postrenal transplant patie...
Objective ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem ce...
With the introduction of hematopoietic stem cell transplant (HSCT), transplant-associated problems l...
ABO incompatibility between the recipient and the donor is not a barrier for successful haematopoiet...
Parvovirus B19 is recognized as a rare cause of pure red cell aplasia (PRCA) in allogeneic stem cell...
Background: Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoie...
ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic stem cell tr...
Pure red cell aplasia (PRCA) is a complication of ABO-incompatible allogeneic stem cell transplantat...
AbstractNo standard of care for pure red cell aplasia (PRCA) after major ABO-incompatible hematopoie...
Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has...
BACKGROUND: Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoie...
We studied a patient who developed pure red cell aplasia (PRCA) following peripheral stem cell trans...
Major ABO incompatibility in stem cell transplant recipients has been associated with pure red cell ...
BACKGROUND: Major ABO mismatch in hematopoietic progenitor cell transplantation (HPCT) is associated...
Pure red cell aplasia (PRCA) is a rare complication in recipients of allogenic stem cell from ABO in...
Acquired pure red cell aplasia (PRCA) is an uncommon cause of anemia in a postrenal transplant patie...
Objective ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem ce...
With the introduction of hematopoietic stem cell transplant (HSCT), transplant-associated problems l...
ABO incompatibility between the recipient and the donor is not a barrier for successful haematopoiet...
Parvovirus B19 is recognized as a rare cause of pure red cell aplasia (PRCA) in allogeneic stem cell...
Background: Persistent anti-donor isoagglutinins after major ABO blood group incompatible hematopoie...
ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic stem cell tr...